| Title : Clinical and cost-effectiveness of donepezil, rivastigmine, and galantamine for Alzheimer's disease. A systematic review - Clegg_2002_Int.J.Technol.Assess.Health.Care_18_497 |
| Author(s) : Clegg A , Bryant J , Nicholson T , McIntyre L , De Broe S , Gerard K , Waugh N |
| Ref : Int J Technol Assess Health Care , 18 :497 , 2002 |
| Abstract : Clegg_2002_Int.J.Technol.Assess.Health.Care_18_497 |
| ESTHER : Clegg_2002_Int.J.Technol.Assess.Health.Care_18_497 |
| PubMedSearch : Clegg_2002_Int.J.Technol.Assess.Health.Care_18_497 |
| PubMedID: 12391943 |
Clegg A, Bryant J, Nicholson T, McIntyre L, De Broe S, Gerard K, Waugh N (2002)
Clinical and cost-effectiveness of donepezil, rivastigmine, and galantamine for Alzheimer's disease. A systematic review
Int J Technol Assess Health Care
18 :497
Clegg A, Bryant J, Nicholson T, McIntyre L, De Broe S, Gerard K, Waugh N (2002)
Int J Technol Assess Health Care
18 :497